Pier Capital, LLC Glaukos Corp Transaction History

Pier Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $1.57 Million - $4.3 Million	-61,305 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$54.18 - $65.64 $42,802 - $51,855	-790 Reduced 1.27%	61,305 $3.34 Million
Q3 2019 Nov 13, 2019	BUY	$58.58 - $83.91 $3.64 Million - $5.21 Million	62,095 New	62,095 $3.88 Million

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.14B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.